The Cigna Group (CI) Price Target Boosted by $7 Following Better-than-Expected Q1

With an upside potential of 20.18% as of May 3, The Cigna Group (NYSE:CI) is included among the 10 Best Fortune 500 Stocks to Buy According to Analysts.

The Cigna Group (CI) Price Target Boosted by $7 Following Better-than-Expected Q1

The Cigna Group (NYSE:CI) is a global health company that provides insurance and related products and services. It operates through two segments: Evernorth Health Services and Cigna Healthcare.

On May 1, Barclays increased its price target on The Cigna Group (NYSE:CI) from $303 to $310, while maintaining an ‘Overweight’ rating on the shares. The raised target, which represents an upside of almost 10% from the current levels, comes following the company’s Q1 report.

The Cigna Group (NYSE:CI) posted strong results for its first quarter on April 30, exceeding estimates in both profits and revenue. The company grew its adjusted EPS by around 16% YoY to $7.79, while its revenue of $68.5 billion was also up by 4.7% compared to last year. Notably, Cigna also revealed that it would exit subsidized plans offered under the Affordable ​Care Act, also known as Obamacare, at the end of this year.

The Cigna Group (NYSE:CI) also raised its full-year 2026 consolidated adjusted earnings per share outlook to at least $30.35, up from the prior guidance of $30.25 and slightly better than the consensus of $30.33.

READ NEXT: 10 Best Blue Chip Stocks to Invest In According to Billionaires and 10 Best Fortune 500 Dividend Stocks to Invest In Right Now

Disclosure: None. Follow Insider Monkey on Google News.